A61P 7/12
Antidiuretics
Official title: Antidiuretics, e.g. drugs for diabetes insipidus (ADH A61P5/10)
A61P7/12 (Antidiuretics) appears on 945 US grants and 1,493 published applications in this corpus.
Search patents in A61P- Granted patents
- 945
- Published applications
- 1,493
- Assignees
- 513
- Inventors
- 2,794
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 10 | 3 |
| 2002 | 17 | 34 |
| 2003 | 22 | 43 |
| 2004 | 17 | 78 |
| 2005 | 23 | 66 |
| 2006 | 38 | 72 |
| 2007 | 32 | 96 |
| 2008 | 32 | 111 |
| 2009 | 53 | 98 |
| 2010 | 63 | 167 |
| 2011 | 67 | 94 |
| 2012 | 76 | 84 |
| 2013 | 105 | 92 |
| 2014 | 86 | 89 |
| 2015 | 67 | 73 |
| 2016 | 42 | 47 |
| 2017 | 45 | 47 |
| 2018 | 35 | 44 |
| 2019 | 27 | 29 |
| 2020 | 18 | 31 |
| 2021 | 20 | 24 |
| 2022 | 9 | 25 |
| 2023 | 12 | 15 |
| 2024 | 10 | 13 |
| 2025 | 5 | 13 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating diabetic kidney disease and glomerular disease9 Jun 2026US 12,649,780 B2Nephris SrL
- Methods of improving renal function24 Mar 2026US 12,582,631 B2Chinook Therapeutics, Inc.
- Methods of improving renal function13 Jan 2026US 12,521,369 B2Chinook Therapeutics, Inc.
- Tricyclic spiro compound16 Dec 2025US 12,497,377 B2Ono Pharmaceutical Co., Ltd.
- Substituted cycloalkanes for managing nephrogenic diabetes insipidus7 Oct 2025US 12,433,858 B2NephroDI Therapeutics, Inc.
- Benzothiazole compound and use thereof3 Sep 2026US 2026/0256772 A1Nanjing Reju Therapeutics, Co., Ltd.
- Methods for treating diabetic kidney disease and glomerular disease6 Aug 2026US 2026/0226144 A1Nephris SrL
- Morphinan derivative11 Jun 2026US 2026/0159517 A1Nippon Chemiphar Co., Ltd.
- Heteroaromatic compounds and their use as dopamine d1 ligands7 May 2026US 2026/0125364 A1Pfizer Inc.
- Methods for producing viloxazine salts and novel polymorphs thereof8 Jan 2026US 2026/0008759 A1Supernus Pharmaceuticals, Inc.
Most cited
By later US patents
- Indwelling heat exchange catheter and method of using same284US 6,338,727 B12002
- Dry powder compositions having improved dispersivity211US 6,518,239 B1Inhale Therapeutic Systems · 2003
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols146US 7,040,314 B2Philip Morris USA Inc. · 2006